发明名称 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
摘要 <p>The present invention relates to novel hydroxyethylamine compounds having Asp2 (beta-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated beta-amyloid levels or beta-amyloid deposits, particularly Alzheimer's disease.</p>
申请公布号 SI1567488(T1) 申请公布日期 2007.08.31
申请号 SI20030030793T 申请日期 2003.12.03
申请人 GLAXO GROUP LIMITED 发明人 DEMONT EMMANUEL;FALLER ANDREW;MACPHERSON DAVID TIMOTHY;MILNER PETER HENRY;NAYLOR ALAN;REDSHAW SALLY;STANWAY STEVEN JAMES;VESEY DAVID R.;WALTER DARYL S.
分类号 A61P25/28;C07D207/26;C07D207/267;C07D211/76;C07D275/02;C07D279/02;C07D401/12;C07D403/12;C07D405/12;C07D409/12;C07D417/12 主分类号 A61P25/28
代理机构 代理人
主权项
地址